Socs1 gene expression is increased in severe pulmonary tuberculosis

Scandinavian Journal of Immunology

Volumn 76, Issue 4, 2012, Pages 398-404

  Masood, K I ^a   Rottenberg, M E ^b   Carow, B ^b   Rao, N ^c   Ashraf, M ^a   Hussain, R ^a   Hasan, Z ^a  

^a AGA KHAN UNIVERSITY   (Pakistan)

^b KAROLINSKA INSTITUTE   (Sweden)

^c DOW UNIVERSITY OF HEALTH SCIENCES   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 6; MESSENGER RNA; SUPPRESSOR OF CYTOKINE SIGNALING 1; SUPPRESSOR OF CYTOKINE SIGNALING 3; TRANSCRIPTION FACTOR GATA 3;

ADULT; ARTICLE; BLOOD; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE COURSE; DISEASE SEVERITY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GENE EXPRESSION; HUMAN; IMMUNITY; INNATE IMMUNITY; LUNG TUBERCULOSIS; LYMPHOCYTE COUNT; LYMPHOCYTE DIFFERENTIATION; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; TUBERCULOSIS CONTROL;

ADOLESCENT; ADULT; AGED; FEMALE; GENE EXPRESSION; HOST-PATHOGEN INTERACTIONS; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-6; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; RNA, MESSENGER; SEVERITY OF ILLNESS INDEX; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TUBERCULOSIS, PULMONARY;

EID: 84866297365     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2012.02731.x     Document Type: Article

References (48)

1. World Health Organisation. Global Tuberculosis Control. Geneva: World Health Organisation, 2009. ISBN: 978 924 156380 2.
2. Flynn JL, Chan J. Tuberculosis: latency and reactivation. Infect Immun 2001;69:4195-201.
3. Fallahi-Sichani M, Schaller MA, Kirschner DE, Kunkel SL, Linderman JJ. Identification of key processes that control Tumor Necrosis Factor availability in a Tuberculosis granuloma. PLoS Comput Biol 2010;6:e1000778.
4. Stenger S, Modlin RL. T cell mediated immunity to Mycobacterium tuberculosis. Curr Opin Microbiol 1999;2:89-93.
5. Dalton DK, Pitts-Meek S, Keshav S, Figari IS, Bradley A, Stewart TA. Multiple defects of immune cell function in mice with disrupted Interferon-gamma genes. Science 1993;259:1739-42.
6. Kaufmann SH. Protection against tuberculosis: cytokines, T cells, and macrophages. Ann Rheum Dis 2002;61 (Suppl. 2):ii54-8.
7. Qiu L, Huang D, Chen CY et al. Severe tuberculosis induces unbalanced up-regulation of gene networks and overexpression of IL-22, MIP-1alpha, CCL27, IP-10, CCR4, CCR5, CXCR3, PD1, PDL2, IL-3, IFN-beta, TIM1, and TLR2 but low antigen-specific cellular responses. J Infect Dis 2008;198:1514-9.
8. Hasan Z, Jamil B, Ashraf M et al. Differential live Mycobacterium tuberculosis-, M. bovis BCG-, recombinant ESAT6-, and Culture Filtrate Protein 10-induced immunity in Tuberculosis. Clin Vaccine Immunol 2009;16:991-8.
9. Hirsch CS, Toossi Z, Othieno C et al. Depressed T-cell Interferon-gamma responses in pulmonary tuberculosis: analysis of underlying mechanisms and modulation with therapy. J Infect Dis 1999;180:2069-73.
10. Sahiratmadja E, Alisjahbana B, de Boer T et al. Dynamic changes in pro- and anti-inflammatory cytokine profiles and Gamma Interferon receptor signaling integrity correlate with Tuberculosis disease activity and response to curative treatment. Infect Immun 2007;75:820-9.
11. Vilcek J, Klion A, Henriksen-DeStefano D et al. Defective Gamma-Interferon production in Peripheral Blood Leukocytes of patients with acute Tuberculosis. J Clin Immunol 1986;6:146-51.
12. Schroder K, Hertzog PJ, Ravasi T, Hume DA. Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol 2004;75:163-89.
13. Imai K, Kurita-Ochiai T, Ochiai K. Mycobacterium bovis bacillus Calmette-Guerin infection promotes SOCS induction and inhibits IFN-gamma-stimulated JAK/STAT signaling in J774 macrophages. FEMS Immunol Med Microbiol 2003;39:173-80.
14. Alexander WS. Suppressors of Cytokine Signalling (SOCS) in the immune system. Nat Rev Immunol 2002;2:410-6.
15. Palmer DC, Restifo NP. Suppressors of Cytokine Signaling (SOCS) in T cell differentiation, maturation, and function. Trends Immunol 2009;30:592-602.
16. Diehl S, Anguita J, Hoffmeyer A et al. Inhibition of Th1 differentiation by IL-6 is mediated by SOCS1. Immunity 2000;13:805-15.
17. Alexander WS, Starr R, Fenner JE et al. SOCS1 is a critical inhibitor of Interferon gamma signaling and prevents the potentially fatal neonatal actions of this cytokine. Cell 1999;98:597-608.
18. El Kasmi KC, Holst J, Coffre M et al. General nature of the STAT3-activated anti-inflammatory response. J Immunol 2006;177:7880-8.
19. Croker BA, Krebs DL, Zhang JG et al. SOCS3 negatively regulates IL-6 signaling in vivo. Nat Immunol 2003;4:540-5.
20. Niemand C, Nimmesgern A, Haan S et al. Activation of STAT3 by IL-6 and IL-10 in primary human macrophages is differentially modulated by Suppressor of Cytokine Signaling 3. J Immunol 2003;170:3263-72.
21. Dlugovitzky D, Torres-Morales A, Rateni L et al. Circulating profile of Th1 and Th2 cytokines in Tuberculosis patients with different degrees of pulmonary involvement. FEMS Immunol Med Microbiol 1997;18:203-7.
22. Sharma SK, Mitra DK, Balamurugan A, Pandey RM, Mehra NK. Cytokine polarization in Miliary and Pleural tuberculosis. J Clin Immunol 2002;22:345-52.
23. Pathan AA, Wilkinson KA, Klenerman P et al. Direct ex vivo analysis of antigen-specific IFN-gamma-secreting CD4 T cells in Mycobacterium tuberculosis-infected individuals: associations with clinical disease state and effect of treatment. J Immunol 2001;167:5217-25.
24. Jamil B, Shahid F, Hasan Z et al. Interferon gamma/IL10 ratio defines the disease severity in pulmonary and extra pulmonary tuberculosis. Tuberculosis (Edinb) 2007;87:279-87.
25. Carow B, Ye X, Gavier-Widen D et al. Silencing Suppressor of Cytokine Signaling-1 (SOCS1) in macrophages improves Mycobacterium tuberculosis control in an Interferon-gamma (IFN-gamma)-dependent manner. J Biol Chem 2011;286:26873-87.
26. Jacobsen M, Repsilber D, Kleinsteuber K et al. Suppressor of Cytokine Signaling-3 is affected in T-cells from Tuberculosis patients. Clin Microbiol Infect 2010;17:1323-31.
27. Mullen AC, High FA, Hutchins AS et al. Role of T-bet in commitment of Th1 cells before IL-12-dependent selection. Science 2001;292:1907-10.
28. Zhou M, Ouyang W. The function role of GATA-3 in Th1 and Th2 differentiation. Immunol Res 2003;28:25-37.
29. Crofton J. Clinical Features of Tuberculosis. Crofton and Douglas's Respiratory Diseases, 4th edn. London: Wiley-blackwell scientific, 1991. ISBN: 978 06320 19731.
30. Hussain R, Hasan R, Khurshid M, Sturm AW, Ellner JJ, Dawood G. Pulmonary tuberculosis in a BCG vaccinated area: relationship of disease severity with immunological and hematological parameters and drug resistance patterns. Southeast Asian J Trop Med Public Health 1996;27:257-62.
31. Aulesa C, Pastor I, Naranjo D, Piqueras J, Galimany R. Validation of the Coulter LH 750 in a hospital reference laboratory. Lab Hematol 2003;9:15-28.
32. Yang T, Stark P, Janik K, Wigzell H, Rottenberg ME. SOCS-1 protects against Chlamydia pneumoniae-induced lethal inflammation but hampers effective bacterial clearance. J Immunol 2008;180:4040-9.
33. Dheda K, Huggett JF, Bustin SA, Johnson MA, Rook G, Zumla A. Validation of housekeeping genes for normalizing RNA expression in Real-time PCR. Biotechniques 2004;116:118-9.
34. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using Real-time quantitative PCR and the 2(-delta delta c(t)) method. Methods 2001;25:402-8.
35. Talat N, Shahid F, Perry S, Dawood G, Hussain R. Th1/Th2 cytometric bead array can discriminate cytokine secretion from endogenously activated cells in pulmonary disease, recent and remote infection in Tuberculosis. Cytokine 2011;54:136-43.
36. Hasan Z, Jamil B, Khan J et al. Relationship between circulating levels of IFN-gamma, IL-10, CXCL9 and CCL2 in pulmonary and extrapulmonary tuberculosis is dependent on disease severity. Scand J Immunol 2009;69:259-67.
37. Egwuagu CE, Yu CR, Zhang M, Mahdi RM, Kim SJ, Gery I. Suppressors of Cytokine Signaling proteins are differentially expressed in Th1 and Th2 cells: implications for Th cell lineage commitment and maintenance. J Immunol 2002;168:3181-7.
38. Naka T, Fujimoto M, Kishimoto T. Negative regulation of cytokine signaling: STAT-induced STAT inhibitor. Trends Biochem Sci 1999;24:394-8.
39. Ellner JJ, Hirsch CS, Whalen CC. Correlates of protective immunity to Mycobacterium tuberculosis in humans. Clin Infect Dis 2000;30 (Suppl. 3):S279-82.
40. Berry MP, Graham CM, McNab FW et al. An Interferon-inducible Neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 2010;466:973-7.
41. Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR. An essential role for Interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med 1993;178:2249-54.
42. Ho JL, Lapa e Silva JR. Promotion of a down-modulated lung immune state may be a strategy by M. tuberculosis to foster active disease and persistence. Discov Med 2010;9:34-41.
43. Deveci F, Akbulut HH, Turgut T, Muz MH. Changes in serum cytokine levels in active Tuberculosis with treatment. Mediators Inflamm 2005;2005:256-62.
44. Redford PS, Murray PJ, O'Garra A. The role of IL-10 in immune regulation during M. tuberculosis infection. Mucosal Immunol 2011;4:261-70.
45. Mattos AM, Almeida Cde S, Franken KL et al. Increased IgG1, IFN-gamma, TNF-alpha and IL-6 responses to Mycobacterium tuberculosis antigens in patients with tuberculosis are lower after chemotherapy. Int Immunol 2010;22:775-82.
46. Hasan Z, Zaidi I, Jamil B, Khan MA, Kanji A, Hussain R. Elevated ex vivo Monocyte Chemotactic Protein-1 (CCL2) in pulmonary as compared with extra-pulmonary tuberculosis. BMC Immunol 2005;6:14.
47. Dlugovitzky D, Bay ML, Rateni L et al. Influence of disease severity on nitrite and cytokine production by peripheral blood mononuclear cells (PBMC) from patients with pulmonary tuberculosis (TB). Clin Exp Immunol 2000;122:343-9.
48. Barry S, Breen R, Lipman M, Johnson M, Janossy G. Impaired antigen-specific CD4(+) T lymphocyte responses in cavitary tuberculosis. Tuberculosis (Edinb) 2009;89:48-53.